Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer

Oncogene

Volumn 23, Issue 26, 2004, Pages 4556-4566

  Ding, Yi ^a   Wang, Li ^a   Su, Li Kuo ^a,b   Frey, Jennifer A ^a,b   Shao, Ruping ^a   Hunt, Kelly K ^a   Yan, Duen Hwa ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Breast cancer; HIN 200; IFIX; Interferon; p21CIPI

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON INDUCIBLE PROTEIN 10 ALPHA1; GAMMA INTERFERON INDUCIBLE PROTEIN 10 ALPHA2; GAMMA INTERFERON INDUCIBLE PROTEIN 10 BETA1; GAMMA INTERFERON INDUCIBLE PROTEIN 10 BETA2; GAMMA INTERFERON INDUCIBLE PROTEIN 10 GAMMA1; GAMMA INTERFERON INDUCIBLE PROTEIN 10 GAMMA2; ISOPROTEIN; LIPOSOME; PROTEIN KINASE; PROTEIN P21; UNCLASSIFIED DRUG; CDK2 PROTEIN, HUMAN; CDK2 PROTEIN, MOUSE; CDKN1A PROTEIN, HUMAN; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; HIN 200 PROTEIN, HUMAN; HIN 200 PROTEIN, MOUSE; HIN-200 PROTEIN, HUMAN; HIN-200 PROTEIN, MOUSE; IFIX PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG SCREENING; GENE TRANSFER; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTERFERON INDUCTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA SPLICING; ALTERNATIVE RNA SPLICING; ANIMAL; BREAST TUMOR; CARCINOGEN TESTING; CELL CULTURE; FEMALE; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MOUSE; NUDE MOUSE;

MUS MUSCULUS;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOGENICITY TESTS; CDC2 PROTEIN KINASE; CDC2-CDC28 KINASES; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN ISOFORMS; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3042621022     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207592     Document Type: Article

References (39)

1. Choubey D. (2000). J. Biol. Regul. Homeost. Agents, 14, 187-192.
2. Choubey D, Walter S, Geng Y and Xin H. (2000). FEBS Lett., 474, 38-42.
3. Coradini D, Pellizzaro C, Biffi A, Lombardi L, Pirronello E, Riva L and Di Fronzo G. (1998). Anticancer Res., 18, 177-182.
4. Cox LS. (1997). J. Pathol., 183, 134-140.
5. Dawson MJ and Trapani JA. (1995). J. Cell. Biochem., 57, 39-51.
6. Dawson MJ and Trapani JA. (1996). J. Leukotr. Biol., 60, 310-316.
7. De Young KL, Ray ME, Su YA, Anzick SL, Johnstone RW, Trapani JA, Melzer PS and Trent JM. (1997). Oncogens, 15, 453-457.
8. Ding Y, Wen Y, Spohn B, Wang L, Xia W, Kwong KY, Shao R, Li Z, Hortobagyi GN, Hung M-C and Yan D-H. (2002). Clin. Cancer Res., 8, 3290-3297.
9. Doree M and Hunt T. (2002). J. Cell Sci., 115, 2461-2464.
10. Dotto GP. (2000). Biochim. Biophys. Acta, 1471, M43-M56.
11. Fairbrother WJ, Gordon NC, Humke EW, O'Rourke KM, Starovasnik MA, Yin JP and Dixit VM. (2001). Protein Sci., 10, 1911-1918.
12. Fang M, Liu B, Schmidt M, Lu Y, Mendelsohn J and Fan Z. (2000). Anticancer Res., 20, 103-111.
13. Funk JO and Galloway DA. (1998). Trends Biochem. Sci., 23, 337-341.
14. Gariglio M, Azzimonti B, Pagano M, Palestro G, De Andrea M, Valante G, Voglino G, Navino L and Landolfo S. (2002). J. Interferon Cytokine Res., 22, 815-821.
15. Gooch JL, Herrera RE and Yee D. (2000). Cell Growth Differ., 11, 335-342.
16. Gribaudo G, Riera L, De Andrea M and Landolfo S. (1999). FEBS Lett., 456, 31-36.
17. Gutterman JU and Choubey D. (1999). Cell Growth Differ., 10, 93-100.
18. Hingorani R, Bi B, Dao T, Bae Y, Matsuzawa A and Crispe IN. (2000). J. Immunol., 164, 4032-4036.
19. Johnstone RW and Trapani JA. (1999). Mol. Cell. Biol., 19, 5833-5838.
20. Kimchi A, Resnitzky D, Ber R and Gat G. (1988). Mol. Cell. Biol., 8, 2828-2836.
21. Lengyel P. (1993). Proc. Natl. Acad. Sci. USA, 90, 5893-5895.
22. Liepinsh E, Barbais R, Dahl E, Sharipo A, Staub E and Otting G. (2003). J. Mol. Biol., 332, 1155-1163.
23. MacLachlan TK, Sang N and Giordano A. (1995). Crit. Rev. Eukaryot. Gene Express., 5, 127-156.
24. Martinon F, Hofmann K and Tschopp J. (2001). Curr. Biol., 11, R118-R120.
25. Nadal A, Jares P, Cazorla M, Fernandez PL, Sanjuan X, Hernandez L, Pinyol M, Aldea M, Mallofre C, Muntane J, Traserra J, Campo E and Cardesa A. (1997). J. Pathol., 183, 156-163.
26. Naldini A, Carney DH, Pucci A and Carraro F. (2002). J. Cell. Physiol., 191, 290-297.
27. Price JE, Polyzos A, Zhang RD and Daniels LM. (1990). Cancer Res., 50, 717-721.
28. Shao R, Karunagaran D, Zhou BP, Li K, Lo S-S. Deng J, Chiao P and Hung M-C. (1997). J. Biol. Chem., 272, 32739-32742.
29. Staub E, Dahl E and Rosenthal A. (2001). Trends Biochem. Sci., 26, 83-85.
30. Wei W, Clarke CJP, Somers GR, Cresswell KS, Loveland KA, Trapani JA and Johnstone RW. (2003). Histochem. Cell. Biol., 119, 45-54.
31. Wen Y, Yan D-H, Wang B, Spohn B, Ding Y, Shao R, Zhou Y, Xie K and Hung M-C. (2001). Cancer Res., 61, 7142-7147.
32. Wen Y, Yan DH, Spohn B, Deng J, Lin SY and Hung MC. (2000). Cancer Res., 60, 42-46.
33. Xie Y and Hung MC. (1994). Biochem. Biophys. Res. Commun., 203, 1589-1598.
34. Yin F, Giuliano AE, Law RE and Van Herle AJ. (2001). Anticancer Res., 21, 413-420.
35. Yu D, Jing T, Liu B, Yao J, Tan M, McDonnell TJ and Hung MC. (1998). Mol. Cell, 2, 581-591.
36. Zhang JF, Hu C, Geng Y, Selm J, Klein SB, Orazi A and Taylor MW. (1996). Proc. Natl. Acad. Sci. USA, 93, 4513-4518.
37. Zhang RD, Fidler IJ and Price JE. (1991). Invasion Metastasis, 11, 204-215.
38. Zhou Y, Wang S, Yue BG, Gobi A and Oberg K. (2002). Cancer Investig., 20, 348-356.
39. Zou Y, Peng H, Zhou B, Wen Y, Wang SC, Tsai EM and Hung MC. (2002). Cancer Res., 62, 8-12.